Is there any progress in the outcome of patients suffering from ovarian cancer? Treatment strategies since 1957

被引：3
作者：
Pfleiderer, A
机构：
来源：
GYNECOLOGIC ONCOLOGY | 2001年 / 83卷 / 03期
关键词：
D O I：
10.1006/gyno.2001.6448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：451 / 456
页数：6
相关论文
共 32 条
  • [1] ANDREESEN R, 1990, CANCER RES, V50, P7450
  • [2] OCCURRENCE OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN ADNEXAL TUMORS AND THEIR PROGNOSTIC VALUE IN ADVANCED OVARIAN CARCINOMAS
    BAUKNECHT, T
    RUNGE, M
    SCHWALL, M
    PFLEIDERER, A
    [J]. GYNECOLOGIC ONCOLOGY, 1988, 29 (02) : 147 - 157
  • [3] Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
    duBois, A
    Luck, HJ
    Bauknecht, T
    Mobus, V
    Bochtler, H
    Diergarten, K
    Meerpohl, HG
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (04) : 355 - 361
  • [4] DUBOIS A, 1992, P AN M AM SOC CLIN, V11, P381
  • [5] DUBOIS A, 1999, P AN M AM SOC CLIN, V18, P356
  • [6] Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101
  • [7] RECURRENT CYTOGENETIC ABERRATIONS AND LOSS OF CONSTITUTIONAL HETEROZYGOSITY IN OVARIAN CARCINOMAS
    KIECHLESCHWARZ, M
    BAUKNECHT, T
    KARCK, U
    KOMMOSS, F
    DUBOIS, A
    PFLEIDERER, A
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 55 (02) : 198 - 205
  • [8] KLEINE W, 1985, AKTUELLE ONKOLOGIE, V17
  • [9] STEROID-RECEPTORS IN OVARIAN-CARCINOMA - IMMUNOHISTOCHEMICAL DETERMINATION MAY LEAD TO NEW ASPECTS
    KOMMOSS, F
    PFISTERER, J
    THOME, M
    SCHAFER, W
    SAUERBREI, W
    PFLEIDERER, A
    [J]. GYNECOLOGIC ONCOLOGY, 1992, 47 (03) : 317 - 322
  • [10] SEQUENTIAL THERAPY WITH CISPLATIN-CYCLOPHOSPHAMIDE AND CISPLATIN-ETOPOSIDE IN ADVANCED OVARIAN-CANCER WITH TUMOR REMNANT GREATER-THAN-2CM
    MEERPOHL, HG
    SAUERBREI, W
    PFLEIDERER, A
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 915 - 917
1234